Pediatric perfusion market seen reaching $4.39 billion by 2030

The global pediatric perfusion market is projected to rise from $2.83 billion in 2025 to $4.39 billion by 2030, driven by congenital heart defect cases, expanding pediatric cardiac surgery, and wider use of ECMO and advanced monitoring. North America held the largest share in 2025 and is expected to stay in the lead as other regions accelerate.

Why it matters: - Pediatric perfusion supports blood circulation, blood pressure, and oxygen delivery during complex pediatric surgeries. - Growing demand for congenital heart defect treatment is expanding the need for specialized perfusion systems and services. - The market’s projected growth points to rising investment in pediatric critical care infrastructure and surgical technology.

What happened: - The Business Research Company released its Pediatric Perfusion Global Market Report 2026, covering market size, trends, and forecasts through 2035. - The report values the pediatric perfusion market at $2.83 billion in 2025 and $3.09 billion in 2026. - The report forecasts the market will reach $4.39 billion by 2030. - The report identifies North America as the largest regional market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa. - A free sample report is available. - The full report is available online.

The details: - The market is expected to grow at a compound annual growth rate of 8.9% from 2025 to 2026. - The forecast period calls for a 9.2% CAGR through 2030. - Historic growth is linked to rising congenital heart defects, expanded pediatric cardiac surgery programs, more pediatric care centers, better neonatal intensive care survival, and advances in extracorporeal circulation. - Future growth is expected to come from pediatric critical care investment, advanced monitoring, minimally invasive pediatric surgery, and broader ECMO use for pediatric respiratory failure. - The report also points to innovation in biocompatible perfusion materials as a growth driver. - Key forecast trends include miniaturized pediatric perfusion devices, ECMO systems for neonatal care, real-time perfusion monitoring, disposable and single-use components, and patient-specific perfusion solutions. - Pediatric perfusion is used to keep blood flowing through the body of pediatric patients during procedures that require continuous circulation support. - The technique is especially important in surgeries such as ventricular septal defect repair, atrial septal defect repair, tetralogy of Fallot repair, and coarctation of the aorta repair. - The World Health Organization reported in February 2023 that congenital diseases cause about 240,000 newborn deaths worldwide in the first 28 days of life each year. - The Centers for Disease Control and Prevention reported in January 2022 that congenital cardiac abnormalities affect around 40,000 births annually in the U.S., or about 1% of births.

Between the lines: - The market outlook suggests pediatric perfusion is shifting from a niche surgical support category toward a broader technology platform tied to neonatal care, ECMO, and monitoring. - North America’s lead likely reflects stronger hospital infrastructure and faster adoption of advanced medical devices. - Growth in emerging regions may depend on how quickly pediatric cardiac care programs and specialized surgical capacity scale.

What's next: - The market is expected to keep expanding as pediatric hospitals adopt smaller devices, more monitoring tools, and more single-use components. - Regional growth outside North America may accelerate as healthcare systems add pediatric cardiac care services. - The Business Research Company says the 2026 report includes market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, market hotspot infographics, and updated trend graphics.